 | • レポートコード：MRC2-11QY11637 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、152ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は糖尿病網膜症（DR）のグローバル市場について調査・分析したレポートです。種類別（レーザー手術、コルチコステロイド注射、抗VEGF薬、硝子体切除術）市場規模、用途別（病院、クリニック・研究所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別糖尿病網膜症（DR）の競争状況、市場シェア ・世界の糖尿病網膜症（DR）市場：種類別市場規模 2015年-2020年（レーザー手術、コルチコステロイド注射、抗VEGF薬、硝子体切除術） ・世界の糖尿病網膜症（DR）市場：種類別市場規模予測 2021年-2026年（レーザー手術、コルチコステロイド注射、抗VEGF薬、硝子体切除術） ・世界の糖尿病網膜症（DR）市場：用途別市場規模 2015年-2020年（病院、クリニック・研究所、その他） ・世界の糖尿病網膜症（DR）市場：用途別市場規模予測 2021年-2026年（病院、クリニック・研究所、その他） ・北米の糖尿病網膜症（DR）市場分析：米国、カナダ ・ヨーロッパの糖尿病網膜症（DR）市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの糖尿病網膜症（DR）市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の糖尿病網膜症（DR）市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの糖尿病網膜症（DR）市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Bayer、F. Hoffmann-La Roche、Novartis、Regeneron Pharmaceuticals、Actavis、Alimera Sciences、Ampio Pharmaceuticals、Antisense Therapeutics、BCN Peptides、Boehringer Ingelheim、Glycadia、iCo Therapeutics、Isis Pharmaceuticals、Kowa Group、Lpath、Numoda Capital、Ohr Pharmaceutical、OPKO Health、Parexel International、Promedior、pSivida、Quark Pharmaceuticals、R-Tech Ueno、Sirnaomics、thromboGenics ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Diabetic retinopathy is a disorder of the eye that damages the blood vessels of the retina. The retina is the light-sensitive inner surface of the eye on which images are formed. Long-term diabetes affects the retina as high blood glucose levels can damage the tiny blood vessels in the retina. Diabetic retinopathy is broadly classified into non-proliferative diabetic retinopathy and proliferative retinopathy. Treatment for diabetic retinopathy depends on the stage of the disease and is directed toward slowing down or stopping the progression of the disease.
Laser surgery, injection of corticosteroids or anti-VEGF drugs into the eye, and vitrectomy are some of the available treatments. One feature of diabetic retinopathy is diabetic macular edema. This is a serious medical condition involving leakage of fluid from the minute, delicate, and previously injured blood vessels located at the back of the eye, which then collects in the macula. This results in inflammation of tissue and blurry vision.
Market Analysis and Insights: Global Diabetic Retinopathy Market
The global Diabetic Retinopathy market size is projected to reach US$ 7034.8 million by 2026, from US$ 6612.1 million in 2020, at a CAGR of 5.9%% during 2021-2026.
Global Diabetic Retinopathy Scope and Market Size
Diabetic Retinopathy market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Diabetic Retinopathy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Bayer
F. Hoffmann-La Roche
Novartis
Regeneron Pharmaceuticals
Actavis
Alimera Sciences
Ampio Pharmaceuticals
Antisense Therapeutics
BCN Peptides
Boehringer Ingelheim
Glycadia
iCo Therapeutics
Isis Pharmaceuticals
Kowa Group
Lpath
Numoda Capital
Ohr Pharmaceutical
OPKO Health
Parexel International
Promedior
pSivida
Quark Pharmaceuticals
R-Tech Ueno
Sirnaomics
thromboGenics
Market segment by Type, the product can be split into
Laser surgery
Injection of corticosteroids
Anti-VEGF drugs
Vitrectomy
Market segment by Application, split into
Hospitals
Clinics and laboratories
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Diabetic Retinopathy Revenue
1.4 Market by Type
1.4.1 Global Diabetic Retinopathy Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Laser surgery
1.4.3 Injection of corticosteroids
1.4.4 Anti-VEGF drugs
1.4.5 Vitrectomy
1.5 Market by Application
1.5.1 Global Diabetic Retinopathy Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics and laboratories
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Diabetic Retinopathy Market Perspective (2015-2026)
2.2 Global Diabetic Retinopathy Growth Trends by Regions
2.2.1 Diabetic Retinopathy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Diabetic Retinopathy Historic Market Share by Regions (2015-2020)
2.2.3 Diabetic Retinopathy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Diabetic Retinopathy Market Growth Strategy
2.3.6 Primary Interviews with Key Diabetic Retinopathy Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Diabetic Retinopathy Players by Market Size
3.1.1 Global Top Diabetic Retinopathy Players by Revenue (2015-2020)
3.1.2 Global Diabetic Retinopathy Revenue Market Share by Players (2015-2020)
3.1.3 Global Diabetic Retinopathy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Diabetic Retinopathy Market Concentration Ratio
3.2.1 Global Diabetic Retinopathy Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Diabetic Retinopathy Revenue in 2019
3.3 Diabetic Retinopathy Key Players Head office and Area Served
3.4 Key Players Diabetic Retinopathy Product Solution and Service
3.5 Date of Enter into Diabetic Retinopathy Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Diabetic Retinopathy Historic Market Size by Type (2015-2020)
4.2 Global Diabetic Retinopathy Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Diabetic Retinopathy Market Size by Application (2015-2020)
5.2 Global Diabetic Retinopathy Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Diabetic Retinopathy Market Size (2015-2020)
6.2 Diabetic Retinopathy Key Players in North America (2019-2020)
6.3 North America Diabetic Retinopathy Market Size by Type (2015-2020)
6.4 North America Diabetic Retinopathy Market Size by Application (2015-2020)
7 Europe
7.1 Europe Diabetic Retinopathy Market Size (2015-2020)
7.2 Diabetic Retinopathy Key Players in Europe (2019-2020)
7.3 Europe Diabetic Retinopathy Market Size by Type (2015-2020)
7.4 Europe Diabetic Retinopathy Market Size by Application (2015-2020)
8 China
8.1 China Diabetic Retinopathy Market Size (2015-2020)
8.2 Diabetic Retinopathy Key Players in China (2019-2020)
8.3 China Diabetic Retinopathy Market Size by Type (2015-2020)
8.4 China Diabetic Retinopathy Market Size by Application (2015-2020)
9 Japan
9.1 Japan Diabetic Retinopathy Market Size (2015-2020)
9.2 Diabetic Retinopathy Key Players in Japan (2019-2020)
9.3 Japan Diabetic Retinopathy Market Size by Type (2015-2020)
9.4 Japan Diabetic Retinopathy Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Diabetic Retinopathy Market Size (2015-2020)
10.2 Diabetic Retinopathy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Diabetic Retinopathy Market Size by Type (2015-2020)
10.4 Southeast Asia Diabetic Retinopathy Market Size by Application (2015-2020)
11 India
11.1 India Diabetic Retinopathy Market Size (2015-2020)
11.2 Diabetic Retinopathy Key Players in India (2019-2020)
11.3 India Diabetic Retinopathy Market Size by Type (2015-2020)
11.4 India Diabetic Retinopathy Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Diabetic Retinopathy Market Size (2015-2020)
12.2 Diabetic Retinopathy Key Players in Central & South America (2019-2020)
12.3 Central & South America Diabetic Retinopathy Market Size by Type (2015-2020)
12.4 Central & South America Diabetic Retinopathy Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Bayer
13.1.1 Bayer Company Details
13.1.2 Bayer Business Overview
13.1.3 Bayer Diabetic Retinopathy Introduction
13.1.4 Bayer Revenue in Diabetic Retinopathy Business (2015-2020))
13.1.5 Bayer Recent Development
13.2 F. Hoffmann-La Roche
13.2.1 F. Hoffmann-La Roche Company Details
13.2.2 F. Hoffmann-La Roche Business Overview
13.2.3 F. Hoffmann-La Roche Diabetic Retinopathy Introduction
13.2.4 F. Hoffmann-La Roche Revenue in Diabetic Retinopathy Business (2015-2020)
13.2.5 F. Hoffmann-La Roche Recent Development
13.3 Novartis
13.3.1 Novartis Company Details
13.3.2 Novartis Business Overview
13.3.3 Novartis Diabetic Retinopathy Introduction
13.3.4 Novartis Revenue in Diabetic Retinopathy Business (2015-2020)
13.3.5 Novartis Recent Development
13.4 Regeneron Pharmaceuticals
13.4.1 Regeneron Pharmaceuticals Company Details
13.4.2 Regeneron Pharmaceuticals Business Overview
13.4.3 Regeneron Pharmaceuticals Diabetic Retinopathy Introduction
13.4.4 Regeneron Pharmaceuticals Revenue in Diabetic Retinopathy Business (2015-2020)
13.4.5 Regeneron Pharmaceuticals Recent Development
13.5 Actavis
13.5.1 Actavis Company Details
13.5.2 Actavis Business Overview
13.5.3 Actavis Diabetic Retinopathy Introduction
13.5.4 Actavis Revenue in Diabetic Retinopathy Business (2015-2020)
13.5.5 Actavis Recent Development
13.6 Alimera Sciences
13.6.1 Alimera Sciences Company Details
13.6.2 Alimera Sciences Business Overview
13.6.3 Alimera Sciences Diabetic Retinopathy Introduction
13.6.4 Alimera Sciences Revenue in Diabetic Retinopathy Business (2015-2020)
13.6.5 Alimera Sciences Recent Development
13.7 Ampio Pharmaceuticals
13.7.1 Ampio Pharmaceuticals Company Details
13.7.2 Ampio Pharmaceuticals Business Overview
13.7.3 Ampio Pharmaceuticals Diabetic Retinopathy Introduction
13.7.4 Ampio Pharmaceuticals Revenue in Diabetic Retinopathy Business (2015-2020)
13.7.5 Ampio Pharmaceuticals Recent Development
13.8 Antisense Therapeutics
13.8.1 Antisense Therapeutics Company Details
13.8.2 Antisense Therapeutics Business Overview
13.8.3 Antisense Therapeutics Diabetic Retinopathy Introduction
13.8.4 Antisense Therapeutics Revenue in Diabetic Retinopathy Business (2015-2020)
13.8.5 Antisense Therapeutics Recent Development
13.9 BCN Peptides
13.9.1 BCN Peptides Company Details
13.9.2 BCN Peptides Business Overview
13.9.3 BCN Peptides Diabetic Retinopathy Introduction
13.9.4 BCN Peptides Revenue in Diabetic Retinopathy Business (2015-2020)
13.9.5 BCN Peptides Recent Development
13.10 Boehringer Ingelheim
13.10.1 Boehringer Ingelheim Company Details
13.10.2 Boehringer Ingelheim Business Overview
13.10.3 Boehringer Ingelheim Diabetic Retinopathy Introduction
13.10.4 Boehringer Ingelheim Revenue in Diabetic Retinopathy Business (2015-2020)
13.10.5 Boehringer Ingelheim Recent Development
13.11 Glycadia
10.11.1 Glycadia Company Details
10.11.2 Glycadia Business Overview
10.11.3 Glycadia Diabetic Retinopathy Introduction
10.11.4 Glycadia Revenue in Diabetic Retinopathy Business (2015-2020)
10.11.5 Glycadia Recent Development
13.12 iCo Therapeutics
10.12.1 iCo Therapeutics Company Details
10.12.2 iCo Therapeutics Business Overview
10.12.3 iCo Therapeutics Diabetic Retinopathy Introduction
10.12.4 iCo Therapeutics Revenue in Diabetic Retinopathy Business (2015-2020)
10.12.5 iCo Therapeutics Recent Development
13.13 Isis Pharmaceuticals
10.13.1 Isis Pharmaceuticals Company Details
10.13.2 Isis Pharmaceuticals Business Overview
10.13.3 Isis Pharmaceuticals Diabetic Retinopathy Introduction
10.13.4 Isis Pharmaceuticals Revenue in Diabetic Retinopathy Business (2015-2020)
10.13.5 Isis Pharmaceuticals Recent Development
13.14 Kowa Group
10.14.1 Kowa Group Company Details
10.14.2 Kowa Group Business Overview
10.14.3 Kowa Group Diabetic Retinopathy Introduction
10.14.4 Kowa Group Revenue in Diabetic Retinopathy Business (2015-2020)
10.14.5 Kowa Group Recent Development
13.15 Lpath
10.15.1 Lpath Company Details
10.15.2 Lpath Business Overview
10.15.3 Lpath Diabetic Retinopathy Introduction
10.15.4 Lpath Revenue in Diabetic Retinopathy Business (2015-2020)
10.15.5 Lpath Recent Development
13.16 Numoda Capital
10.16.1 Numoda Capital Company Details
10.16.2 Numoda Capital Business Overview
10.16.3 Numoda Capital Diabetic Retinopathy Introduction
10.16.4 Numoda Capital Revenue in Diabetic Retinopathy Business (2015-2020)
10.16.5 Numoda Capital Recent Development
13.17 Ohr Pharmaceutical
10.17.1 Ohr Pharmaceutical Company Details
10.17.2 Ohr Pharmaceutical Business Overview
10.17.3 Ohr Pharmaceutical Diabetic Retinopathy Introduction
10.17.4 Ohr Pharmaceutical Revenue in Diabetic Retinopathy Business (2015-2020)
10.17.5 Ohr Pharmaceutical Recent Development
13.18 OPKO Health
10.18.1 OPKO Health Company Details
10.18.2 OPKO Health Business Overview
10.18.3 OPKO Health Diabetic Retinopathy Introduction
10.18.4 OPKO Health Revenue in Diabetic Retinopathy Business (2015-2020)
10.18.5 OPKO Health Recent Development
13.19 Parexel International
10.19.1 Parexel International Company Details
10.19.2 Parexel International Business Overview
10.19.3 Parexel International Diabetic Retinopathy Introduction
10.19.4 Parexel International Revenue in Diabetic Retinopathy Business (2015-2020)
10.19.5 Parexel International Recent Development
13.20 Promedior
10.20.1 Promedior Company Details
10.20.2 Promedior Business Overview
10.20.3 Promedior Diabetic Retinopathy Introduction
10.20.4 Promedior Revenue in Diabetic Retinopathy Business (2015-2020)
10.20.5 Promedior Recent Development
13.21 pSivida
10.21.1 pSivida Company Details
10.21.2 pSivida Business Overview
10.21.3 pSivida Diabetic Retinopathy Introduction
10.21.4 pSivida Revenue in Diabetic Retinopathy Business (2015-2020)
10.21.5 pSivida Recent Development
13.22 Quark Pharmaceuticals
10.22.1 Quark Pharmaceuticals Company Details
10.22.2 Quark Pharmaceuticals Business Overview
10.22.3 Quark Pharmaceuticals Diabetic Retinopathy Introduction
10.22.4 Quark Pharmaceuticals Revenue in Diabetic Retinopathy Business (2015-2020)
10.22.5 Quark Pharmaceuticals Recent Development
13.23 R-Tech Ueno
10.23.1 R-Tech Ueno Company Details
10.23.2 R-Tech Ueno Business Overview
10.23.3 R-Tech Ueno Diabetic Retinopathy Introduction
10.23.4 R-Tech Ueno Revenue in Diabetic Retinopathy Business (2015-2020)
10.23.5 R-Tech Ueno Recent Development
13.24 Sirnaomics
10.24.1 Sirnaomics Company Details
10.24.2 Sirnaomics Business Overview
10.24.3 Sirnaomics Diabetic Retinopathy Introduction
10.24.4 Sirnaomics Revenue in Diabetic Retinopathy Business (2015-2020)
10.24.5 Sirnaomics Recent Development
13.25 thromboGenics
10.25.1 thromboGenics Company Details
10.25.2 thromboGenics Business Overview
10.25.3 thromboGenics Diabetic Retinopathy Introduction
10.25.4 thromboGenics Revenue in Diabetic Retinopathy Business (2015-2020)
10.25.5 thromboGenics Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Diabetic Retinopathy Key Market Segments
Table 2. Key Players Covered: Ranking by Diabetic Retinopathy Revenue
Table 3. Ranking of Global Top Diabetic Retinopathy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Diabetic Retinopathy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Laser surgery
Table 6. Key Players of Injection of corticosteroids
Table 7. Key Players of Anti-VEGF drugs
Table 8. Key Players of Vitrectomy
Table 9. Global Diabetic Retinopathy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Diabetic Retinopathy Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Diabetic Retinopathy Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Diabetic Retinopathy Market Share by Regions (2015-2020)
Table 13. Global Diabetic Retinopathy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Diabetic Retinopathy Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Diabetic Retinopathy Market Growth Strategy
Table 19. Main Points Interviewed from Key Diabetic Retinopathy Players
Table 20. Global Diabetic Retinopathy Revenue by Players (2015-2020) (Million US$)
Table 21. Global Diabetic Retinopathy Market Share by Players (2015-2020)
Table 22. Global Top Diabetic Retinopathy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetic Retinopathy as of 2019)
Table 23. Global Diabetic Retinopathy by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Diabetic Retinopathy Product Solution and Service
Table 26. Date of Enter into Diabetic Retinopathy Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Diabetic Retinopathy Market Size by Type (2015-2020) (Million US$)
Table 29. Global Diabetic Retinopathy Market Size Share by Type (2015-2020)
Table 30. Global Diabetic Retinopathy Revenue Market Share by Type (2021-2026)
Table 31. Global Diabetic Retinopathy Market Size Share by Application (2015-2020)
Table 32. Global Diabetic Retinopathy Market Size by Application (2015-2020) (Million US$)
Table 33. Global Diabetic Retinopathy Market Size Share by Application (2021-2026)
Table 34. North America Key Players Diabetic Retinopathy Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Diabetic Retinopathy Market Share (2019-2020)
Table 36. North America Diabetic Retinopathy Market Size by Type (2015-2020) (Million US$)
Table 37. North America Diabetic Retinopathy Market Share by Type (2015-2020)
Table 38. North America Diabetic Retinopathy Market Size by Application (2015-2020) (Million US$)
Table 39. North America Diabetic Retinopathy Market Share by Application (2015-2020)
Table 40. Europe Key Players Diabetic Retinopathy Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Diabetic Retinopathy Market Share (2019-2020)
Table 42. Europe Diabetic Retinopathy Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Diabetic Retinopathy Market Share by Type (2015-2020)
Table 44. Europe Diabetic Retinopathy Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Diabetic Retinopathy Market Share by Application (2015-2020)
Table 46. China Key Players Diabetic Retinopathy Revenue (2019-2020) (Million US$)
Table 47. China Key Players Diabetic Retinopathy Market Share (2019-2020)
Table 48. China Diabetic Retinopathy Market Size by Type (2015-2020) (Million US$)
Table 49. China Diabetic Retinopathy Market Share by Type (2015-2020)
Table 50. China Diabetic Retinopathy Market Size by Application (2015-2020) (Million US$)
Table 51. China Diabetic Retinopathy Market Share by Application (2015-2020)
Table 52. Japan Key Players Diabetic Retinopathy Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Diabetic Retinopathy Market Share (2019-2020)
Table 54. Japan Diabetic Retinopathy Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Diabetic Retinopathy Market Share by Type (2015-2020)
Table 56. Japan Diabetic Retinopathy Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Diabetic Retinopathy Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Diabetic Retinopathy Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Diabetic Retinopathy Market Share (2019-2020)
Table 60. Southeast Asia Diabetic Retinopathy Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Diabetic Retinopathy Market Share by Type (2015-2020)
Table 62. Southeast Asia Diabetic Retinopathy Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Diabetic Retinopathy Market Share by Application (2015-2020)
Table 64. India Key Players Diabetic Retinopathy Revenue (2019-2020) (Million US$)
Table 65. India Key Players Diabetic Retinopathy Market Share (2019-2020)
Table 66. India Diabetic Retinopathy Market Size by Type (2015-2020) (Million US$)
Table 67. India Diabetic Retinopathy Market Share by Type (2015-2020)
Table 68. India Diabetic Retinopathy Market Size by Application (2015-2020) (Million US$)
Table 69. India Diabetic Retinopathy Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Diabetic Retinopathy Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Diabetic Retinopathy Market Share (2019-2020)
Table 72. Central & South America Diabetic Retinopathy Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Diabetic Retinopathy Market Share by Type (2015-2020)
Table 74. Central & South America Diabetic Retinopathy Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Diabetic Retinopathy Market Share by Application (2015-2020)
Table 76. Bayer Company Details
Table 77. Bayer Business Overview
Table 78. Bayer Product
Table 79. Bayer Revenue in Diabetic Retinopathy Business (2015-2020) (Million US$)
Table 80. Bayer Recent Development
Table 81. F. Hoffmann-La Roche Company Details
Table 82. F. Hoffmann-La Roche Business Overview
Table 83. F. Hoffmann-La Roche Product
Table 84. F. Hoffmann-La Roche Revenue in Diabetic Retinopathy Business (2015-2020) (Million US$)
Table 85. F. Hoffmann-La Roche Recent Development
Table 86. Novartis Company Details
Table 87. Novartis Business Overview
Table 88. Novartis Product
Table 89. Novartis Revenue in Diabetic Retinopathy Business (2015-2020) (Million US$)
Table 90. Novartis Recent Development
Table 91. Regeneron Pharmaceuticals Company Details
Table 92. Regeneron Pharmaceuticals Business Overview
Table 93. Regeneron Pharmaceuticals Product
Table 94. Regeneron Pharmaceuticals Revenue in Diabetic Retinopathy Business (2015-2020) (Million US$)
Table 95. Regeneron Pharmaceuticals Recent Development
Table 96. Actavis Company Details
Table 97. Actavis Business Overview
Table 98. Actavis Product
Table 99. Actavis Revenue in Diabetic Retinopathy Business (2015-2020) (Million US$)
Table 100. Actavis Recent Development
Table 101. Alimera Sciences Company Details
Table 102. Alimera Sciences Business Overview
Table 103. Alimera Sciences Product
Table 104. Alimera Sciences Revenue in Diabetic Retinopathy Business (2015-2020) (Million US$)
Table 105. Alimera Sciences Recent Development
Table 106. Ampio Pharmaceuticals Company Details
Table 107. Ampio Pharmaceuticals Business Overview
Table 108. Ampio Pharmaceuticals Product
Table 109. Ampio Pharmaceuticals Revenue in Diabetic Retinopathy Business (2015-2020) (Million US$)
Table 110. Ampio Pharmaceuticals Recent Development
Table 111. Antisense Therapeutics Business Overview
Table 112. Antisense Therapeutics Product
Table 113. Antisense Therapeutics Company Details
Table 114. Antisense Therapeutics Revenue in Diabetic Retinopathy Business (2015-2020) (Million US$)
Table 115. Antisense Therapeutics Recent Development
Table 116. BCN Peptides Company Details
Table 117. BCN Peptides Business Overview
Table 118. BCN Peptides Product
Table 119. BCN Peptides Revenue in Diabetic Retinopathy Business (2015-2020) (Million US$)
Table 120. BCN Peptides Recent Development
Table 121. Boehringer Ingelheim Company Details
Table 122. Boehringer Ingelheim Business Overview
Table 123. Boehringer Ingelheim Product
Table 124. Boehringer Ingelheim Revenue in Diabetic Retinopathy Business (2015-2020) (Million US$)
Table 125. Boehringer Ingelheim Recent Development
Table 126. Glycadia Company Details
Table 127. Glycadia Business Overview
Table 128. Glycadia Product
Table 129. Glycadia Revenue in Diabetic Retinopathy Business (2015-2020) (Million US$)
Table 130. Glycadia Recent Development
Table 131. iCo Therapeutics Company Details
Table 132. iCo Therapeutics Business Overview
Table 133. iCo Therapeutics Product
Table 134. iCo Therapeutics Revenue in Diabetic Retinopathy Business (2015-2020) (Million US$)
Table 135. iCo Therapeutics Recent Development
Table 136. Isis Pharmaceuticals Company Details
Table 137. Isis Pharmaceuticals Business Overview
Table 138. Isis Pharmaceuticals Product
Table 139. Isis Pharmaceuticals Revenue in Diabetic Retinopathy Business (2015-2020) (Million US$)
Table 140. Isis Pharmaceuticals Recent Development
Table 141. Kowa Group Company Details
Table 142. Kowa Group Business Overview
Table 143. Kowa Group Product
Table 144. Kowa Group Revenue in Diabetic Retinopathy Business (2015-2020) (Million US$)
Table 145. Kowa Group Recent Development
Table 146. Lpath Company Details
Table 147. Lpath Business Overview
Table 148. Lpath Product
Table 149. Lpath Revenue in Diabetic Retinopathy Business (2015-2020) (Million US$)
Table 150. Lpath Recent Development
Table 151. Numoda Capital Company Details
Table 152. Numoda Capital Business Overview
Table 153. Numoda Capital Product
Table 154. Numoda Capital Revenue in Diabetic Retinopathy Business (2015-2020) (Million US$)
Table 155. Numoda Capital Recent Development
Table 156. Ohr Pharmaceutical Company Details
Table 157. Ohr Pharmaceutical Business Overview
Table 158. Ohr Pharmaceutical Product
Table 159. Ohr Pharmaceutical Revenue in Diabetic Retinopathy Business (2015-2020) (Million US$)
Table 160. Ohr Pharmaceutical Recent Development
Table 161. OPKO Health Company Details
Table 162. OPKO Health Business Overview
Table 163. OPKO Health Product
Table 164. OPKO Health Revenue in Diabetic Retinopathy Business (2015-2020) (Million US$)
Table 165. OPKO Health Recent Development
Table 166. Parexel International Company Details
Table 167. Parexel International Business Overview
Table 168. Parexel International Product
Table 169. Parexel International Revenue in Diabetic Retinopathy Business (2015-2020) (Million US$)
Table 170. Parexel International Recent Development
Table 171. Promedior Company Details
Table 172. Promedior Business Overview
Table 173. Promedior Product
Table 174. Promedior Revenue in Diabetic Retinopathy Business (2015-2020) (Million US$)
Table 175. Promedior Recent Development
Table 176. pSivida Company Details
Table 177. pSivida Business Overview
Table 178. pSivida Product
Table 179. pSivida Revenue in Diabetic Retinopathy Business (2015-2020) (Million US$)
Table 180. pSivida Recent Development
Table 181. Quark Pharmaceuticals Company Details
Table 182. Quark Pharmaceuticals Business Overview
Table 183. Quark Pharmaceuticals Product
Table 184. Quark Pharmaceuticals Revenue in Diabetic Retinopathy Business (2015-2020) (Million US$)
Table 185. Quark Pharmaceuticals Recent Development
Table 186. R-Tech Ueno Company Details
Table 187. R-Tech Ueno Business Overview
Table 188. R-Tech Ueno Product
Table 189. R-Tech Ueno Revenue in Diabetic Retinopathy Business (2015-2020) (Million US$)
Table 190. R-Tech Ueno Recent Development
Table 191. Sirnaomics Company Details
Table 192. Sirnaomics Business Overview
Table 193. Sirnaomics Product
Table 194. Sirnaomics Revenue in Diabetic Retinopathy Business (2015-2020) (Million US$)
Table 195. Sirnaomics Recent Development
Table 196. thromboGenics Company Details
Table 197. thromboGenics Business Overview
Table 198. thromboGenics Product
Table 199. thromboGenics Revenue in Diabetic Retinopathy Business (2015-2020) (Million US$)
Table 200. thromboGenics Recent Development
Table 201. Research Programs/Design for This Report
Table 202. Key Data Information from Secondary Sources
Table 203. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Diabetic Retinopathy Market Share by Type: 2020 VS 2026
Figure 2. Laser surgery Features
Figure 3. Injection of corticosteroids Features
Figure 4. Anti-VEGF drugs Features
Figure 5. Vitrectomy Features
Figure 6. Global Diabetic Retinopathy Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Clinics and laboratories Case Studies
Figure 9. Others Case Studies
Figure 10. Diabetic Retinopathy Report Years Considered
Figure 11. Global Diabetic Retinopathy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Diabetic Retinopathy Market Share by Regions: 2020 VS 2026
Figure 13. Global Diabetic Retinopathy Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Diabetic Retinopathy Market Share by Players in 2019
Figure 16. Global Top Diabetic Retinopathy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetic Retinopathy as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Diabetic Retinopathy Revenue in 2019
Figure 18. North America Diabetic Retinopathy Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Diabetic Retinopathy Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Diabetic Retinopathy Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Diabetic Retinopathy Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Diabetic Retinopathy Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Diabetic Retinopathy Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Diabetic Retinopathy Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
糖尿病網膜症（DR）治療薬の世界市場（～2026年） Diabetic retinopathy is an ophthalmic disorder, in which blindness occurrs due to complications in diabetes. The North American region is the most lucrative market, owing to large number of elderly population in the U.S. However, European and Asia-Pacific regions are considered as the most promising…- 黄斑変性症（AMD）・糖尿病性網膜症（DR）治療薬の世界市場（～2026年） Age related macular degeneration (AMD) is a medical condition that results in loss of vision in the central visual field, owing to damage to the retina. This is usually an age-related disorder, which affects adults with the age 50 and above. Diabetic retinopathy is an ophthalmic disorder, in which b…
- 増殖性糖尿病性網膜症の世界市場（～2026年） Market Analysis and Insights: Global Proliferative Diabetic Retinopathy Market The global Proliferative Diabetic Retinopathy market size is projected to reach US$ 455.6 million by 2026, from US$ 430.5 million in 2020, at a CAGR of 5.4%% during 2021-2026. Global Proliferative Diabetic Retinopathy Sco…
- 糖尿病網膜症（DR）治療の世界市場（～2026年） Diabetic retinopathy (die-uh-BET-ik ret-ih-NOP-uh-thee) is a diabetes complication that affects eyes. It's caused by damage to the blood vessels of the light-sensitive tissue at the back of the eye (retina). Market Analysis and Insights: Global Diabetic Retinopathy Treatment Market The global Diabet…
- 増殖性糖尿病性網膜症治療治療薬の世界市場（～2026年） Market Analysis and Insights: Global Proliferative Diabetic Retinopathy Therapeutics Market The global Proliferative Diabetic Retinopathy Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Proliferative Diabe…